Abramson Cancer Center - University of Pennsylvania (UPENN)
University of Pennsylvania
Philadelphia, PA
Filters
Save & Share
Clear Filters
Diagnosis
Treatment History
Accepting patients
CARTITUDE-2
Phase 2, Open-Label Study Evaluating the Use of an Investigational CAR-T Cell therapy in Participants with Multiple Myeloma
Learn more- CAR T Cell
- BCMA
- Phase 2
Not yet accepting
MonumenTAL-8
A Phase 2, Open-Label, Multicenter Study of Ciltacabtagene Autoleucel and Talquetamab for the Treatment of Participants With High-Risk Multiple Myeloma
Learn more- Bispecific Antibody
- CAR T Cell
- BCMA
- GPRC5D
- Phase 2
All clinical trials have eligibility criteria - or a list of reasons why you may be able or unable to participate in a trial. Answer a few questions to view your personalized results - all in under 60 seconds.
Help me find trialsAccepting patients
DRAMMATIC
S1803, Lenalidomide +/- Daratumumab/rHuPh20 as Post-ASCT Maintenance for MM w/MRD to Direct Therapy Duration (DRAMMATIC)
Learn more- Monoclonal Antibody
- CD38
- Maintenance
- Phase 3
Accepting patients
Teclistamab
Phase 2, Single-Arm, Non-Inferiority Study Of Limited-Duration Teclistamab For Relapsed Refractory Multiple Myeloma
Learn more- Bispecific Antibody
- BCMA
- Phase 2
Accepting patients
Cevostamab after CAR-T Cell Therapy
Phase 2 Study of Cevostamab Consolidation Following BCMA CAR T Cell Therapy for Relapsed/Refractory Multiple Myeloma
Learn more- Bispecific Antibody
- FCRH5
- Post-CAR T
- Phase 2
Accepting patients
Investigational Cord Blood Units
Safety Study of Unlicensed, Investigational Cord Blood Units Manufactured by the National Cord Blood Program (NCBP) for Unrelated Transplantation
Learn more- Allogeneic Stem Cell Transplant
- Cord Blood
- Phase 2
Accepting patients
Tasquinimod
Tasquinimod for the Treatment of Relapsed or Refractory Myeloma
Learn more- S100A9 Inhibitor
- Phase 1
Accepting patients
Belantamab Mafodotin
Study of Belantamab Mafodotin as Pre- and Post-autologous Stem Cell Transplant and Maintenance for Multiple Myeloma
Learn more- Antibody Drug Conjugate (ADC)
- Autologous Stem Cell Transplant
- BCMA
- Maintenance
- Phase 2
Accepting patients
Low-Dose Radiotherapy for Bone Metastases
Low-Dose Radiotherapy in Treating Painful Bone Metastases in Patients With Multiple Myeloma
Learn more- Radiation
- Phase 2
Accepting patients
CART 38
Phase 1 Study of Lintivirally Transduced T Cells Engineered to Contain Anti-CD38 Linked to TCRζ and 4-1BB Signaling Domains in Subjects With Acute Myeloid Leukemia and Multiple Myeloma
Learn more- CAR T Cell
- CD38
- Phase 1